Abstract
Purpose
Hysteroscopic surgery is considered the gold standard for the minimal invasive treatment of many endouterine diseases such as endometrial polyps or submucous myomas. Recently, many studies have evaluated the effect of preoperative administration of a number of drugs to reduce endometrial thickness and achieve important intraoperative advantages. The purpose of this systematic review is to summarize the available evidence about the use of Dienogest, an orally administrable progestin, for endometrial preparation before hysteroscopic surgery.
Methods
All studies published on this topic and indexed on PubMed/MEDLINE, Embase or Google scholar databases were retrieved and analysed.
Results
We retrieved five studies about this topic. Considered together, the published data analyses allow us to conclude that Dienogest is effective in reducing the thickness of the endometrium, the severity of bleeding and also of operative time, with a lower number of side effects compared with other pharmacological preparations or no treatment.
Conclusion
Administration of Dienogest may be an effective and safe treatment for endometrial thinning before operative hysteroscopy. However, this conclusion is based on few reports and further studies to prove or disprove it are warranted.
Similar content being viewed by others
References
Di Spiezio Sardo A, Bettocchi S, Spinelli M et al (2010) Review of new office-based hysteroscopic procedures 2003–2009. J Minim Invasive Gynecol 17:436–448. doi:10.1016/j.jmig.2010.03.014
Gizzo S, Saccardi C, Di Gangi S et al (2014) Secondary amenorrhea in severe Asherman’s syndrome: step by step fertility retrieval by Bettocchi’s hysteroscope: some considerations. Minim Invasive Ther Allied Technol 23:115–119. doi:10.3109/13645706.2013.835736
Laganà AS, Ciancimino L, Mancuso A et al (2014) 3D sonohysterography vs hysteroscopy: a cross-sectional study for the evaluation of endouterine diseases. Arch Gynecol Obstet 290:1173–1178. doi:10.1007/s00404-014-3366-6
Sudano MC, Vitale SG, Rapisarda AMC et al (2015) The REP-b (removal of endometrial pathologies-basket) in-office hysteroscopy. Updates Surg. doi:10.1007/s13304-015-0294-3
Bradley LD (2002) Complications in hysteroscopy: prevention, treatment and legal risk. Curr Opin Obstet Gynecol 14:409–415. doi:10.1097/00001703-200208000-00008
Kayatas S, Meseci E, Tosun OA et al (2014) Experience of hysteroscopy indications and complications in 5, 474 cases. Clin Exp Obstet Gynecol 41:451–454. doi:10.12891/ceog17502014
Deffieux X, Gauthier T, Menager N et al (2013) Prevention of the complications related to hysteroscopy: guidelines for clinical practice. J Gynecol Obstet Biol Reprod (Paris) 42:1032–1049. doi:10.1016/j.jgyn.2013.09.008
Shveiky D, Rojansky N, Revel A et al (2007) Complications of hysteroscopic surgery: “Beyond the learning curve”. J Minim Invasive Gynecol 14:218–222. doi:10.1016/j.jmig.2006.07.019
Giacobbe V, Rossetti D, Vitale SG et al (2016) Otorrhagia and nosebleed as first signs of intravascular absorption syndrome during hysteroscopy: from bench to bedside. Kathmandu Univ Med J 14:87–89
Rai VS, Gillmer MDG, Gray W (2000) Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium? Hum Reprod 15:1989–1992
Parazzini F, Vercellini P, De Giorgi O et al (1998) Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: Literature review. Hum Reprod 13:2592–2597. doi:10.1093/humrep/13.9.2592
Florio P, Filippeschi M, Imperatore A et al (2012) The practicability and surgeons’ subjective experiences with vaginal danazol before an operative hysteroscopy. Steroids 77:528–533. doi:10.1016/j.steroids.2012.01.017
Cicinelli E, Pinto V, Tinelli R et al (2007) Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study. Fertil Steril 88:698–701. doi:10.1016/j.fertnstert.2006.11.151
Bifulco G, Di Spiezio Sardo A, De Rosa N et al (2012) The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study. Gynecol Endocrinol 28:949–955. doi:10.3109/09513590.2012.683078
Tan YH, Lethaby A (2013) Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev. doi:10.1002/14651858.CD010241.pub2
Triolo O, De Vivo A, Benedetto V et al (2006) Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation. Fertil Steril 85:1027–1031. doi:10.1016/j.fertnstert.2005.09.034
Laganà AS, Palmara V, Granese R et al (2014) Desogestrel versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation. Gynecol Endocrinol 30:794–797. doi:10.3109/09513590.2014.929658
Shin D, Lee S, Lim KS et al (2013) Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women. Contraception 87:750–755. doi:10.1016/j.contraception.2012.10.033
Zeun S, Lu M, Uddin A et al (2009) Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 14:221–232. doi:10.1080/13625180902850039
Strowitzki T, Faustmann T, Gerlinger C et al (2015) Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Womens Health 7:393–401. doi:10.2147/IJWH.S77202
Mori T, Ito F, Matsushima H et al (2015) Dienogest reduces HSD17β1 expression and activity in endometriosis. J Endocrinol 225:69–76. doi:10.1530/JOE-15-0052
Sofo V, Götte M, Laganà AS et al (2015) Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Arch Gynecol Obstet. doi:10.1007/s00404-015-3739-5
Miyashita M, Koga K, Takamura M et al (2014) Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis. Gynecol Endocrinol 3590:1–5. doi:10.3109/09513590.2014.911279
Vetvicka V, Laganà AS, Salmeri FM et al (2016) Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet. doi:10.1007/s00404-016-4195-6
Laganà AS, Triolo O, Salmeri FM et al (2016) Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner. Arch Gynecol Obstet 293:941–949. doi:10.1007/s00404-015-4004-7
Angioni S, Cofelice V, Pontis A et al (2014) New trends of progestins treatment of endometriosis. Gynecol Endocrinol 30:769–773. doi:10.3109/09513590.2014.950646
Bizzarri N, Remorgida V, Leone Roberti Maggiore U et al (2014) Dienogest in the treatment of endometriosis. Expert Opin Pharmacother 15:1889–1902. doi:10.1517/14656566.2014.943734
Maniglio P, Ricciardi E, Laganà AS et al (2016) Epigenetic modifications of primordial reproductive tract: a common etiologic pathway for Mayer–Rokitansky–Kuster–Hauser Syndrome and endometriosis? Med Hypotheses 90:4–5. doi:10.1016/j.mehy.2016.02.015
Petraglia F, Hornung D, Seitz C et al (2012) Reduced pelvic pain in women with endometriosis: efficacy of long-term Dienogest treatment. Arch Gynecol Obstet 285:167–173. doi:10.1007/s00404-011-1941-7
Triolo O, Laganà AS, Sturlese E (2013) Chronic pelvic pain in endometriosis: an overview. J Clin Med Res 5:153–163
Laganà AS, Vitale SG, Trovato MA et al (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:1–8. doi:10.1155/2016/3617179
White K, Potter JE, Hopkins K et al (2012) Contraindications to progestin-only oral contraceptive pills among reproductive-aged women. Contraception 86:199–203. doi:10.1016/j.contraception.2012.01.008
Hall KS, Trussell J, Schwarz EB (2012) Progestin-only contraceptive pill use among women in the United States. Contraception 86:653–658. doi:10.1016/j.contraception.2012.05.003
Sugimoto K, Nagata C, Hayashi H et al (2015) Use of dienogest over 53 weeks for the treatment of endometriosis. J Obstet Gynaecol Res 41:1921–1926. doi:10.1111/jog.12811
de Andres MP, Lopes LA, Baracat EC, Podgaec S (2015) Dienogest in the treatment of endometriosis: systematic review. Arch Gynecol Obstet 292:523–529. doi:10.1007/s00404-015-3681-6
Schindler AE (2011) Dienogest in long-term treatment of endometriosis. Int J Womens Health 3:175–184. doi:10.2147/IJWH.S5633
Laganà AS, Giacobbe V, Triolo O et al (2016) Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study. Gynecol Endocrinol 32:408–411. doi:10.3109/09513590.2015.1128409
Zorzela L, Loke YK, Ioannidis JP et al (2016) PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ 352:i157. doi:10.1136/bmj.i157
Kodama M, Onoue M, Otsuka H et al (2013) Efficacy of Dienogest in thinning the endometrium before hysteroscopic surgery. J Minim Invasive Gynecol 20:790–795. doi:10.1016/j.jmig.2013.04.020
Cicinelli E, Pinto V, Quattromini P et al (2012) Endometrial preparation with estradiol plus Dienogest (Qlaira) for office hysteroscopic polypectomy: randomized pilot study. J Minim Invasive Gynecol 19:356–359. doi:10.1016/j.jmig.2011.12.020
Tsuchiya T, Katagiri Y, Maemura T et al (2016) Preoperative dienogest to improve the surgical field of view in resectoscopic surgery. Gynecol Minim Invasive Ther 5:16–19. doi:10.1016/j.gmit.2015.01.011
Banno K, Kisu I, Yanokura M et al (2012) Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (Review). Int J Oncol 40:1755–1762. doi:10.3892/ijo.2012.1384
Saito F, Tashiro H, Yamaguchi M et al (2016) Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms. Gynecol Endocrinol 32:403–407. doi:10.3109/09513590.2015.1124411
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The work was not supported by any Grant/fund.
Conflict of interest
The authors have no proprietary, financial, professional or other personal interest of any nature in any product, service or company. The authors alone are responsible for the content and writing of the paper.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Laganà, A.S., Vitale, S.G., Muscia, V. et al. Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet 295, 661–667 (2017). https://doi.org/10.1007/s00404-016-4244-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4244-1